Article Versions Notes

Peikert K, Glaß H, Federti E, Matte A, Pelzl L, Akgün K, Ziemssen T, Ordemann R, Lang F, Patients TNfTRfN, et al. Targeting Lyn Kinase in Chorea-Acanthocytosis: A Translational Treatment Approach in a Rare Disease. Journal of Personalized Medicine. 2021; 11(5):392. https://doi.org/10.3390/jpm11050392

Peikert, Kevin, Hannes Glaß, Enrica Federti, Alessandro Matte, Lisann Pelzl, Katja Akgün, Tjalf Ziemssen, Rainer Ordemann, Florian Lang, The Network for Translational Research for Neuroacanthocytosis Patients, and et al. 2021. "Targeting Lyn Kinase in Chorea-Acanthocytosis: A Translational Treatment Approach in a Rare Disease" Journal of Personalized Medicine 11, no. 5: 392. https://doi.org/10.3390/jpm11050392

Peikert, K., Glaß, H., Federti, E., Matte, A., Pelzl, L., Akgün, K., Ziemssen, T., Ordemann, R., Lang, F., Patients, T. N. f. T. R. f. N., De Franceschi, L., & Hermann, A. (2021). Targeting Lyn Kinase in Chorea-Acanthocytosis: A Translational Treatment Approach in a Rare Disease. Journal of Personalized Medicine, 11(5), 392. https://doi.org/10.3390/jpm11050392